Exact Sciences' Blood-Based Colon Cancer Screening Data Surpasses Expectations at ESMO
Velsera Technology Achieves Milestone with FDA Approval of Illumina TruSight™ Oncology Comprehensive IVD, Advancing Cancer Diagnostics
ESMO 2024: GSK/iTeos's TIGIT Shows Promise in NSCLC, Intensifying the Competitive Landscape
Strand Life Sciences Introduces Liquid Biopsy Test to Enhance Cancer Diagnosis
Leading Digital Pathology Solutions for Enhanced Diagnosis and Research
FDA Approves Roche's Tecentriq Hybreza, First Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy
ICMR Collaborates with Industry and Academia to Initiate First-in-Human Phase 1 Clinical Trials
Leveraging Precision Medicine and Multiomic Approaches for the Diagnosis and Treatment of Sepsis
UAE: Genetic Testing Required for Citizens Marrying in Abu Dhabi Starting October 1
PathPresenter Secures $7.5 Million to Drive Adoption of Digital Pathology Workflow Solutions
Sanofi, RadioMedix, and Orano Med Partner on Next-Generation Radioligand Therapy for Rare Cancers
MedGenome Names Dr. Amit Kakar as New Chairman of the Board
Lausanne Researchers Leverage 10x Genomics' Chromium and Xenium Technologies for New Insights into Brain Cancer Resistance and Therapeutic Opportunities
REVEAL GENOMICS® Reports Positive Top-line Results for HER2DX® in Phase III CLEOPATRA Trial
SOPHiA GENETICS and AstraZeneca Partner to Expand Global Access to Liquid Biopsy Testing
